Candida Fratazzi MD has 25 years’ experience in biomedical research. Dr Fratazzi devised the concept of a Strategic Clinical Innovation Organization (SCIO) and founded the first SCIO –Boston Biotech Clinical Research (BBCR), LLC in 2009, with the objective of actively contributing to innovation in clinical research. Dr. Candida Fratazzi is an Orphan Diseases expert: she has worked in cystic fibrosis, Fabry disease, Gaucher’s disease, and multiple sclerosis projects. As the President of BBCR, LLC, Dr. Fratazzi acts as a consultant to biotech, pharmaceutical and medical device companies of all sizes, advising her clients on optimum clinical plan development and how to design clinical trials that reduce the risk of late-stage failure. Dr Fratazzi has held senior positions at Wyeth, Shire, TKT, Vitex and Altus Pharmaceuticals. Her experience encompasses all stages of clinical research. Her most recent achievements include: Recipient of the Cambridge Award for Pharmaceutical Consultant 2013, Developed and presented workshops: BIO Conference 2011 and 2012, Invited speaker: ACRP 2012; MBC 2010 and 2011; GLG 2011 and authored several book chapters